K-numberK250851
Device nameHypnos (369054-200)
ApplicantCadwell Industries, Inc.
Product codeOLZ
Device classClass II
Decision dateDec 14, 2025
DecisionSubstantially Equivalent
Regulation882.1400
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Hypnos is a software application for polysomnography (PSG) and clinical sleep studies that measures, records, displays, analyzes, and retrieves physiological signals during sleep and wake to assist in assessing sleep and diagnosing sleep disorders including sleep-related breathing disorders. It is intended for use by trained medical professionals in hospitals, sleep centers, and clinics for patients from neonate to adult, with computer-assisted analysis features limited to adults only.

Technological characteristics

Hypnos has equivalent technological characteristics to the predicate device, including the ability to acquire, display, store and archive PSG data; perform FFT analysis; detect respiratory events, sleep staging, arousals, limb movements, snore events, and oxygen desaturation; display heart rate, CO2, and oximetry data; and generate customizable reports following AASM scoring standards. Both the subject and predicate devices use mouse/keyboard input, receive data from separate acquisition hardware, and visualize signals and events in equivalent ways.

Test standards cited

Software testing was conducted per IEC 62304:2015-06; risk management per ISO 14971:2019; usability testing per IEC 62366-1:2020-06; and user information per ISO 20417:2021-04. All verification, validation, and usability testing was performed per design requirements.

Substantial equivalence argument

Hypnos presents no new questions of safety and effectiveness and is substantially equivalent to the predicate devices based on: (1) equivalent intended use for PSG analysis and sleep disorder diagnosis by trained professionals; (2) equivalent primary functions including opening studies, displaying data, manually and computer-assisted scoring, and report generation; and (3) clinical performance testing showing computer-assisted scoring achieves above 80% event annotation across all valid clinical event types with confidence intervals comparable to the reference predicate EnsoSleep.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →